Editors' ChoiceCancer

Everything you splice can and will be used against you

See allHide authors and affiliations

Science Translational Medicine  21 Sep 2016:
Vol. 8, Issue 357, pp. 357ec151
DOI: 10.1126/scitranslmed.aah7025

Article Information

vol. 8 no. 357 357ec151

DOI: 
https://doi.org/10.1126/scitranslmed.aah7025
Published By: 
American Association for the Advancement of Science
Print ISSN: 
1946-6234
Online ISSN: 
1946-6242
History: 
    Copyright & Usage: 
    Copyright © 2016, American Association for the Advancement of Science

    Author Information

    1. Saar Gill
    1. Division of Hematology-Oncology, Department of Medicine, University of Pennsylvania, Philadelphia, PA 19104, USA. Email: saar.gill{at}uphs.upenn.edu

    Altmetric

    Article usage

    Article usage: September 2016 to April 2019

    AbstractFullPdf
    Sep 201603630
    Oct 20160510
    Nov 2016092
    Dec 2016080
    Jan 2017090
    Feb 20170250
    Mar 20170240
    Apr 20170440
    May 20170220
    Jun 20170170
    Jul 20170260
    Aug 20170290
    Sep 20170360
    Oct 20170310
    Nov 20170360
    Dec 20170270
    Jan 20180230
    Feb 20180220
    Mar 20180250
    Apr 20180280
    May 20180350
    Jun 20180360
    Jul 20180200
    Aug 20180170
    Sep 20180150
    Oct 20180190
    Nov 20180300
    Dec 20180180
    Jan 20190180
    Feb 20190240
    Mar 20190230
    Apr 20190110

    View Full Text

    Article Tools

    • Email
    • Alerts

    • Citation tools

    • Everything you splice can and will be used against you

      By Saar Gill

      Science Translational Medicine : 357ec151

      Leukemia progenitor cells are characterized by unique splice isoform patterns and are selectively sensitized to spliceosome modulation.

      CiteULike logo Connotea logo del.icio.us logo Digg logo Facebook logo Google logo Mendeley logo Reddit logo Twitter logo

    Related Content

    Similar Articles in:

    Citing Articles in:

    Navigate This Article